drugset / Trial / NCT01069302

Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan

NCT01069302 ↗

Phase 4 Completed 106 enrolled Takeshi Morimoto
RandomizedFactorialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of high dose clopidogrel as the antiplatelet therapy on inhibition of platelet aggregation in Japanese patients scheduled for percutaneous coronary intervention due to ischemic heart disease.

Timeline

Start
2010-02
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg —
Comparator Clopidogrel Small molecule 150 mg —